Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.

Incurable Autoimmune Disease Systemic Lupus Erythematosus (SLE): New Genetic Findings Open Up Perspectives for Future Therapeutic Approaches Jan. 14, 2024 — Systemic lupus erythematosus (SLE ...

However, symptoms often overlap with those of systemic lupus erythematosus (SLE). These include: muscle and joint pain sometimes with swelling flu-like symptoms of fatigue and fever serositis ...

A total of 53–80% of systemic lupus erythematosus (SLE) patients identify fatigue as one of their primary symptoms. Fatigue results in decreased quality of life, increased risk of work ...

The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in ...

The Saint Louis University Division of Rheumatology specializes in the care of both adults and children with rheumatic diseases with an emphasis on rheumatoid arthritis (RA), juvenile idiopathic ...

The following is a summary of “Factors associated with worsening interstitial fibrosis/tubular atrophy in lupus nephritis ...

Saphnelo (anifrolumab-fnia) is a prescription drug used to treat systemic lupus erythematosus (SLE). It is given as an intravenous (IV) infusion by a healthcare professional. Saphnelo is used to ...

Just 5% of pediatric providers feel highly confident in evaluating and managing neuropsychiatric SLE in youth.

Key points A 47-year-old French-speaking woman of African descent presented to the emergency department with a 1-week history of severe foot pain and difficulty walking. For the preceding 2 months she ...